A month af­ter GSK's win in Zan­tac can­cer case, plain­tiffs file dozens more suits

GSK now has dozens more Zan­tac law­suits to con­tend with.

Plain­tiffs on Wednes­day filed 88 suits against GSK in Delaware court on be­half of more than 7,000 claimants who al­lege the pop­u­lar ran­i­ti­dine heart­burn prod­ucts caused a range of can­cers. Pfiz­er, Boehringer In­gel­heim and Sanofi, which owned Zan­tac rights at var­i­ous points in time, were al­so named in the suit, in ad­di­tion to Ther­mo Fish­er’s Patheon Man­u­fac­tur­ing Ser­vices.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.